top of page
Browse by category
Search
Researcher 2 Researcher and Bariatric News - The Podcasts
Spend an engaging hour with Researcher 2 Researcher and Bariatric News as we explore a range of topics in Bariatric and Metabolic...
By-Band-Sleeve trial: RYGB betters LSG on weight loss and quality-of-life outcomes
Outcomes from the By-Band-Sleeve trial has confirmed the safety and effectiveness of bariatric and metabolic surgery (BMS) and that...
Expanding access to anti-obesity medications delivers 13% return on investment for society
A USC Schaeffer Center white paper entitled, ‘Lifetime Social Returns From Expanding Access to Anti-Obesity Medication’, finds expanded...
BMS demonstrates superior efficacy over non-surgical treatments in managing obesity and associated metabolic disorders
A systematic review and meta-analysis of randomised clinical trials (RCTs) underscores the superior efficacy of bariatric and metabolic...
Chchd10 protein's regulation of adipose tissue suggests new obesity management strategies
Researchers from the Department of Pharmacology and Pharmacy, LKS Faculty of Medicine at the University of Hong Kong (HKUMed), identified...
Expert consensus: AI poised to revolutionise the future of BMS ethical considerations must be addressed
An international consensus panel of 68 leading bariatric and metabolic surgery (BMS) from 35 countries has concluded that there are...
Adding AOMs soon after behavioural therapy significantly enhances weight loss
Adding an anti-obesity medication just one month after behavioural therapy begins - rather than waiting the currently recommended six...
GT Metabolic expands MagDI System with FDA clearance of 50mm magnet
The FDA has cleared GT Metabolic Solutions’ larger, 50mm MagDISystem magnet to complement the system's existing 40mm magnet. This...
Semaglutide before bariatric surgery does not improve weight loss or safety, suggesting a ‘surgery-first strategy’ could lead to better outcomes
Total weight loss did not increase for patients who took semaglutide before having BMS, suggesting that a surgery-first strategy could...
Ten-year SM-BOSS outcomes: RYGB betters LSG for %EBMIL, GERD and revisions
In this randomized clinical trial, RYGB led to significantly higher %EBMIL in the PP population compared to SG beyond 10 years’...
Browse by tag
bottom of page